These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 11181923

  • 1. Pharmacological characterization of locomotor sensitization induced by chronic phencyclidine administration.
    Phillips M, Wang C, Johnson KM.
    J Pharmacol Exp Ther; 2001 Mar; 296(3):905-13. PubMed ID: 11181923
    [Abstract] [Full Text] [Related]

  • 2. Chronic phencyclidine induces behavioral sensitization and apoptotic cell death in the olfactory and piriform cortex.
    Johnson KM, Phillips M, Wang C, Kevetter GA.
    J Neurosci Res; 1998 Jun 15; 52(6):709-22. PubMed ID: 9669320
    [Abstract] [Full Text] [Related]

  • 3. Augmentation of locomotor activity by chronic phencyclidine is associated with an increase in striatal NMDA receptor function and an upregulation of the NR1 receptor subunit.
    Hanania T, Hillman GR, Johnson KM.
    Synapse; 1999 Mar 01; 31(3):229-39. PubMed ID: 10029241
    [Abstract] [Full Text] [Related]

  • 4. A preliminary investigation into the effects of antipsychotics on sub-chronic phencyclidine-induced deficits in attentional set-shifting in female rats.
    McLean SL, Beck JP, Woolley ML, Neill JC.
    Behav Brain Res; 2008 May 16; 189(1):152-8. PubMed ID: 18282619
    [Abstract] [Full Text] [Related]

  • 5. Effect of MS-153 on the development of behavioral sensitization to locomotion- and ataxia-inducing effects of phencyclidine.
    Abekawa T, Honda M, Ito K, Inoue T, Koyama T.
    Psychopharmacology (Berl); 2002 Mar 16; 160(2):122-31. PubMed ID: 11875629
    [Abstract] [Full Text] [Related]

  • 6. Subchronic phencyclidine in rats: alterations in locomotor activity, maze performance, and GABA(A) receptor binding.
    Beninger RJ, Beuk J, Banasikowski TJ, van Adel M, Boivin GA, Reynolds JN.
    Behav Pharmacol; 2010 Feb 16; 21(1):1-10. PubMed ID: 19949321
    [Abstract] [Full Text] [Related]

  • 7. Altered adult locomotor activity in rats from phencyclidine treatment on postnatal days 7, 9 and 11, but not repeated ketamine treatment on postnatal day 7.
    Boctor SY, Ferguson SA.
    Neurotoxicology; 2010 Jan 16; 31(1):42-54. PubMed ID: 19853622
    [Abstract] [Full Text] [Related]

  • 8. Activation of medial prefrontal cortex neurons by phencyclidine is mediated via AMPA/kainate glutamate receptors in anesthetized rats.
    Katayama T, Jodo E, Suzuki Y, Hoshino KY, Takeuchi S, Kayama Y.
    Neuroscience; 2007 Dec 05; 150(2):442-8. PubMed ID: 17935894
    [Abstract] [Full Text] [Related]

  • 9. Repeated low dose of phencyclidine administration impairs spatial learning in mice: blockade by clozapine but not by haloperidol.
    Beraki S, Kuzmin A, Tai F, Ogren SO.
    Eur Neuropsychopharmacol; 2008 Jul 05; 18(7):486-97. PubMed ID: 18242064
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Blockade of N-methyl-D-aspartate receptors by phencyclidine causes the loss of corticostriatal neurons.
    Wang C, Anastasio N, Popov V, Leday A, Johnson KM.
    Neuroscience; 2004 Jul 05; 125(2):473-83. PubMed ID: 15062989
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pharmacodynamics of a monoclonal antiphencyclidine Fab with broad selectivity for phencyclidine-like drugs.
    Hardin JS, Wessinger WD, Proksch JW, Owens SM.
    J Pharmacol Exp Ther; 1998 Jun 05; 285(3):1113-22. PubMed ID: 9618414
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Clozapine and cocaine effects on dopamine and serotonin release in nucleus accumbens during psychostimulant behavior and withdrawal.
    Broderick PA, Hope O, Okonji C, Rahni DN, Zhou Y.
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan 05; 28(1):157-71. PubMed ID: 14687870
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.